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Available online 28 November 2018Background: Sexual health (SH) services increasingly need to prioritise those at greatest risk of sexually transmit-
ted infections (STIs). We used SH surveillance data to develop algorithms to triage individuals attending SH ser-
vices within two high-risk populations: men who have sex with men (MSM) and young people (YP).
Methods: Separate multivariable logistic regression models for MSM and YP were developed using surveillance
data on demographics, recent sexual history, prior STI diagnoses and drug/alcohol use from ﬁve clinics in
2015–2016 to identify factors associated with new STI diagnoses. The models were prospectively applied in
one SH clinic in May 2017 as an external validation.
Findings: 9530 YP and 1448MSM SH episodes informedmodel development. For YP, factors associatedwith new
STI diagnosis (overall prevalence: 10.6%) were being of black or mixed white/black ethnicity; history of chla-
mydia diagnosis (previous year); and multiple partners/new partner (previous 3-months). The YPs model had
reasonable performance (c-statistic: 0.703), but poor discrimination when externally validated (c-statistic:
0.539). For MSM, being of South Asian ethnicity; being born in Europe (excluding the UK); and condomless
anal sex or drug use (both in previous 3-months) were associated with STI diagnosis (overall prevalence:
22.0%). The MSM model had a c-statistic of 0.676, reducing to 0.579 on validation.
Interpretation: SH surveillance data, including limited behavioural data, enabled triage algorithms to be devel-
oped, but its implementation may be problematic due to poor external performance. This approach may be
more suitable to self-triage, including online, ensuring patients are directed towards appropriate services.
Funding: NIHR HTA programme (12/191/05).0Guilford Street







Routine data1. IntroductionSexually transmitted infections (STIs) remain prevalent in England,
with the highest rates seen in young people (YP) and men who have
sex with men (MSM) [1,2]. Behavioural interventions can reduce risky
sexual behaviours, increase testing and ultimately reduce STI incidence,
and attendance at a sexual health clinic provides an opportunity for
targeted intervention delivery [3–6]. However, funding for sexual
health services in England has decreased since 2016, with reductions
of up to 20% occurring alongside overall increases in attendance [7,8].
Data driven triage, developed through predictive statistical models,
is relatively common in primary and secondary clinical care [9], such, LondonWC1N
e under the CC BY-NCas the Framingham risk score which supports treatment decisions for
cardiovascular disease [10]. In sexual health, triage is common-place
[11,12], with clinics stratifying patients according to symptoms, behav-
ioural risks and demographics to receive different services, such as
‘quick checks’ or safe-guarding [13,14]. However, these triage ap-
proaches focus primarily on dichotomous pre-deﬁned criteria rather
than using statistical, population-levelmodels,whichmaynot necessar-
ily take into account risk behaviours or identify individual patientsmost
in need of interventions [15].
Since 2008, sexual health clinics in England have reported all STI ser-
vices and diagnoses to a nationally mandated STI surveillance system
(GUMCAD) [16,17]. This has allowed monitoring of trends in STI diagno-
ses, but has lacked information on risk behaviours for more detailed risk
stratiﬁcation. To improve monitoring of the patient case-mix and-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Research in context
Evidence before this study
A search was conducted in May 2018 of PubMed and Embase
databases using the following search terms: (triag* OR algorithm
OR score) AND (STI OR ‘sexually transmitted infection’ OR ‘sexual
health’). Papers were considered that included STI risk algorithm
development, validation or evaluation of introduction into routine
care. Studies which focussed on risks of acquiring a single infection
(e.g. HIV), related to the biological diagnosis of an infection, ap-
pointment booking systems or were published prior to 2000 were
excluded. We found 11 examples of risk algorithms that used de-
mographic, sexual history and behavioural data to develop risk
tools, conducted in Australia (n = 2), Canada (n = 1), USA (n =
6), the Netherland (n = 1) and South Africa (n = 1). Of these
only two considered all STIs as the outcomeandbothwere amongst
young people, with others focussed speciﬁcally on HIV (n = 5) or
combinations of chlamydia, gonorrhoea and trichomonas (n = 4).
All studies showed reasonable or good model discrimination, with
c-statistics in development models ranging from 0.72 to 0.89. Vali-
dation models, which used a range of internal and external ap-
proaches such as geographical and temporal validation, showed
reduced performance (c-statistics: 0.64–0.86). The existing data
suggest that this approach could be appropriate for tailoring inter-
ventions or types of services based on risk. However, no studies
were found that evaluated the impact of these models to direct pa-
tients into sexual risk reduction interventions, using all STIs as the
outcome in MSM or using electronic patient records in the UK.
Added value of this study
Our study is theﬁrst thatweknowof from theUK that uses elec-
tronic surveillance data collected within sexual health clinics,
alongside an external prospective validation, to triage service
users according to STI risk. Compared to previously published stud-
ies, we used a comprehensive STI outcome and included data in the
development model from ﬁve different sexual health services that
are geographically dispersed and offer different levels of services.
We developed separate models for young people (aged
16–25 years old) and men who have sex with men, and found
they had marginally lower discrimination (i.e. ability to differenti-
ate between those with and without an STI) than those in previ-
ously published studies (c-statistic = 0.70 and 0.68, respectively).
Implications of all the available evidence
Our study supports previously published evidence that predic-
tive risk algorithms for STI diagnosis which have reasonable ability
to discriminate between people with and without an STI diagnosis
based on a combination of demographic, sexual history and behav-
iour data. However, the evidence-base for scaling-up these triage
approaches across diverse clinical settings, geographies and patient
proﬁles, is lacking. Further work is needed on how these models
can be further reﬁned with existing electronic surveillance data,
and how they can be integrated into sexual health services which
transition to offering both online self-testing and clinic-based
pathways.
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hancedGUMCADdataset including additional behavioural and sexual his-
tory variables collected during routine patient consultations, asrecommended by the British Association for Sexual Health and HIV
(BASHH) [18–20]. Electronic patient record (EPR) systems facilitate the
capture of these standardised risk behaviours, providing an opportunity
to implement and automate triaging within sexual health clinics without
expending considerable resources. Examples of triage tools using this ap-
proach in sexual health have been developed in other high-income set-
tings, and have shown reasonable ability to predict STI diagnoses [21–23].
We aimed to develop and validate triagemodels for young people and
MSM using electronic surveillance data collected from sexual health
clinics in England, to stratify patients according to their risk of STI diagno-
sis. This work was conducted as part of a larger pilot feasibility study
(Santé Project; ISRCTN: 16738765). The wider aim of this project was to
identify and adapt evidence-based brief behavioural risk reduction inter-
ventions that could be delivered routinely within sexual health clinics,
such as a motivational interviewing session with a health advisor, and
use automated triage models to refer “higher risk” service users into
this intervention.
2. Methods
We developed two predictive models, one for YP and one for MSM,
using data collected as part of a pilot of an enhanced speciﬁcation of
GUMCAD, conducted by PHE in 2015–2016. We prospectively imple-
mented the two models in a single sexual health clinic Brighton in May
2017, as part of pilot trial of the triaging process and delivery of a brief
motivational interviewing session for “higher risk” patients. The data
collected during this pilot was used to externally validate the models.
2.1. Enhanced GUMCAD Surveillance Pilot
The dataset used formodel developmentwas generated during a pilot
of an enhanced GUMCAD speciﬁcation by PHE from July 2015 to June
2016 [19]. This enhancement has now been approved for routine imple-
mentation in England. Five clinics located in southern England, including
two in Greater London, took part. Four clinics were comprehensive spe-
cialist STI services for all patients and one was speciﬁcally a young
person's clinic run by Brook (a sexual health charity for young people).
The dataset included routinely-collected, standardised information on
STI diagnoses and patient demographics [17], and additional data on re-
cent sexual behaviours, drug and alcohol use, and partner notiﬁcations
(Supplementary Table 1). The behavioural variables were based on
those recommended for sexual history taking by BASHH and are well-
supported in the literature as being risks for STI acquisition [20].
2.2. Deﬁnitions
Young people were deﬁned as all women, and men who self-
reported as heterosexual and reported no sex with men in the previous
3-months, aged 16–25 years old. MSM were deﬁned as men who re-
ported any sex with men in the previous 3-months, or self-reported as
bisexual or homosexual, aged 16 and over. Within the GUMCAD data
collected during the study period, genderwas coded as a binary variable
based on patient's self-reported gender. This means that we were un-
able to differentiate between or include non-binary and trans-gender
identities in the models.
The outcome for both models was a new speciﬁed STI diagnosis at
the current clinic attendance, including: HIV; primary, secondary or
early latent syphilis; gonorrhoea; chlamydia; hepatitis A, B and C; lym-
phogranuloma venereum (LGV); trichomonas; or herpes. Recurrent
herpes, genital warts and non-speciﬁc genital infections were excluded.
Demographic predictors included: categorised age; quintiles of
socio-economic status using the Index of Multiple Deprivation score,
derived from the patient's area of residence [24]; self-reported ethnic-
ity, country of birth, sexual orientation, and gender; HIV status; and
STI diagnosis in the previous 12months based on clinical records. Previ-
ous STI diagnosis included only those diagnosed within the same clinic
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cluded in both models were: number of sexual partners in the last 3-
months; problematic alcohol use, assessed using a standardised tool ac-
cording to local clinical guidelines; and any recreational drug use in the
last 3-months. Young person speciﬁc variables were deﬁned as: any
newpartners in the last 3-months and condomuse at last sex.MSMspe-
ciﬁc variables were deﬁned as: condomless anal intercourse (CAI) and
sex with known HIV positive partners in the last 3-months. These pre-
dictors were decided a priori based on published literature and
guidelines.
2.3. Sample Size
As we used secondary data for model development, we did not con-
duct an a priori sample size calculation. However, as a general rule to
prevent over-ﬁtting, 10 outcome events (i.e. STI diagnoses) per degree
of freedom in themodel (i.e. predictor variable) are recommended [25].
2.4. Model Development
All pre-deﬁned variables were included in the primary models, ex-
cept if missing datawere too common, and after re-categorisation to re-
duce degrees of freedom and merge empty or low frequency cells.
Continuous variables were investigated for linearity with the log odds
of STI diagnosis andmodelled as splines, continuous and categorical; in-
teraction terms for age, ethnicity and genderwere also investigated.We
opted for the simplest model, without interaction terms and using cat-
egorical variables, comparing models using the Bayesian Information
Criteria (BIC) to check whether they were statistically supported. Re-
garding missing data, we assumed data may not be missing at random
(i.e. we assumed data may be missing depending on its value), and
therefore standard multiple imputation may not be valid and was not
used as our primary approach. In addition, if a variable has high levels
of missing data, then its inclusion in a triage tool may be impractical
[26]. We chose a pragmatic primary approach of including variables
with less than one third missing data and coded missingness as a dis-
tinct category retaining all observations in the model. Variables with
more than one third missing data were excluded.
Multivariable logistic regression, using a maximum likelihood ap-
proach, was used to generate themodels in Stata SE14, with default set-
tings. Global p-values were calculated using Wald tests with Stata's
post-estimation command -test-. Model calibration was assessed with
the Hosmer-Lemeshow goodness of ﬁt test [27,28], and model discrim-
ination was based on the c-statistic [26,29]. A c-statistic of N0.8 is con-
sidered strong discrimination and N0.7 as reasonable for a clinical
tool; 0.5 indicates performance the same as chance at predicting the
outcome [30]. Sensitivity and speciﬁcities were calculated for different
model prediction thresholds. The range of the predicted probabilities
of the outcome from across the participants was described. Internal val-
idation was conducted using k-fold cross-validation, with 10 folds.
The following sensitivity analyses were conducted to vary model as-
sumptions andmethodology: 1. A forward stepwise approach (with a p-
value threshold of b0.2) to model selection to explore the performance
of a potentially more parsimonious model; 2. A model including only
demographic data to evaluate the added-value of behavioural variables;
3. Imputing missing values (10 imputations with chained equations) in
variables with less than one third missing. All analyses were conducted
in Stata SE14.
2.5. External Validation
External validation is recommended as an independent assessment
of model performance to assess the extent of over-ﬁtting and the
resulting optimism of its performance in practice [31]. Both models
were externally validated during a prospective implementation of the
triaging process at a large sexual health clinic in May 2017. Wecompared the model's predictions of STI diagnosis with each patient's
actual STI diagnosis, calculating the c-statistic and sensitivity and spec-
iﬁcity for different model thresholds.
Patients attending the clinic during speciﬁc time blocks over a one-
month periodwere asked to self-complete the demographic and behav-
ioural questions on tablets in the waiting room by a member of study
staff. On completing the questionnaire, a ticket was printed containing
a random study ID number which clinic staff were asked to enter into
the clinic's EPR system. The data from the tablet-based system were
linked to clinic records using the study ID number, and if not available
deterministic matching was undertaken using: date of attendance,
time of appointment, patient age and gender.
3. Results
A total of 28,514 episodes of care were recorded in the enhanced
GUMCAD pilot, including 9530 young people and 1448 MSM
(Table 1). The STI diagnosis prevalence in YP was 10.6% (n = 1005;
95% CI: 9.9%, 11.1%) and 22.0% (n = 318; 95% CI: 19.9%, 24.2%) in
MSM. This was similar to the national average during the same time pe-
riod for young people (10.6% vs. 10.8%), but higher in MSM (22.0% vs.
14.9%). Young people andMSM differed from each other in terms of be-
havioural data, withMSM twice as likely to report any recreational drug
use compared to young people (14% versus 7%), and 15% of MSM
reporting ≥5 partners in the previous 3-months compared to only 2%
in young people. MSM had less missing data (Table 1).
3.1. Young Person's Model
Amongst young people, we included prior chlamydia diagnosis
rather than all STIs as exploratory analyses showed that it improved
model ﬁt. Drug and problematic alcohol use were excluded due tomiss-
ing data; sexual orientation was excluded as it was one of the eligibility
criteria for men. The primary model included 34 degrees of freedom,
meeting the required 10 outcomes per degree of freedom.
Being female and older were associated with lower odds of STI diag-
nosis, while being of black or mixed white and black ethnicity had
higher odds of STI diagnosis, compared to being white British
(Table 2). Signiﬁcant behavioural risks included: chlamydia diagnosis
in the previous year, having one or more partners compared to none
and having a new partner in the prior 3-months. Condom use at last
sex was protective. The model had reasonable performance, with a c-
statistic of 0.703 (Fig. 1a), and the Hosmer-Lemeshow test did not
raise concerns about model ﬁt (p-value = 0.160). Following internal
validation, the c-statistic reduced slightly to 0.687. The predicted prob-
abilities of STI diagnosis ranged from 1 to 75%, with a mean of 12%.
Fig. 2a plots the model's predicted risk of STI diagnosis against the pop-
ulation risk percentile, demonstrating the range in predicted risks, and
suggesting that the risk of STI diagnosis is concentrated in a small per-
centage of the population. Taking an example, wherewe prioritise a bal-
ance between sensitivity and speciﬁcity, a predicted risk of STI diagnosis
of ≥10%would result in a sensitivity of 67%, speciﬁcity of 63%, andwould
classify 40% of patients as “high risk” (Figs. 1a and 2a).
Sensitivity analysis using a forward stepwise approach retained all
variables. A model ﬁtted using multiple imputation for missing values
showed similar performance (c-statistic: 0.688), and a slightly narrower
range of predicted risks (1–68%). The magnitude and direction of asso-
ciations were similar to the primary model. Using demographic data
only showed considerably worse model performance (c-statistic:
0.590) and a limited range of predicted risks (2–24%).
3.2. MSM Model
AmongstMSM, a range of prior STI diagnoseswere reported (includ-
ingHIV, syphilis, chlamydia and gonorrhoea), but contained too few ob-
servations as individual predictors, therefore a single binary variable
Table 1
Description of GUMCADv3 enhanced surveillance data.








Gender Male 9491 (41%) 2983 (31%) 1448 (100%)
Female 13,612 (59%) 6547 (69%) –
Age 16–20 years 2938 (13%) 2628 (18%) 77 (5%)
20–24 years 6052 (26%) 6902 (82%) 297 (21%)
25–34 years 8664 (38%) – 562 (39%)
35–44 years 3291 (14%) – 262 (18%)
45–64 years 2007 (9%) – 213 (15%)
≥65 years 151 (1%) – 37 (3%)
Sexual orientationa Heterosexual 17,758 (77%) 7809 (82%) 51 (4%)
Bisexual 540 (2%) 120 (1%) 299 (21%)
Homosexual 1034 (4%) 27 (0%) 963 (67%)
Missing 3771 (16%) 1574 (17%) 135 (9%)
Country/continent
of birth
UK 15,682 (68%) 6813 (71%) 1049 (72%)
Europe 2095 (9%) 643 (7%) 153 (11%)
Africa 1134 (5%) 309 (3%) 40 (3%)
Americas 821 (4%) 217 (2%) 43 (3%)
Asia 289 (1%) 51 (1%) 19 (1%)
Other 618 (3%) 190 (2%) 54 (4%)
Missing 2464 (11%) 1307 (14%) 90 (6%)
Ethnicity White
British
13,639 (59%) 6072 (64%) 1003 (69%)
Other White 2554 (11%) 785 (8%) 185 (13%)
South Asian 661 (3%) 201 (2%) 33 (2%)
Other Asian 463 (2%) 165 (2%) 36 (2%)
Black
Caribbean
1353 (6%) 448 (5%) 28 (2%)
Other Black 2379 (10%) 991 (10%) 54 (4%)
White &
Black mixed
826 (4%) 418 (4%) 31 (2%)
Other Mixed 548 (2%) 249 (3%) 38 (3%)
Any Other 233 (1%) 79 (1%) 17 (1%)




Lowest 4731 (20%) 1744 (18%) 294 (20%)
2nd quintile 6019 (26%) 2364 (25%) 354 (24%)
3rd quintile 4257 (18%) 1768 (19%) 259 (18%)
4th quintile 4291 (19%) 1937 (20%) 273 (19%)
Highest 2917 (13%) 1363 (14%) 213 (15%)
Missing 888 (4%) 354 (4%) 55 (4%)
Previous STI
diagnosisb
No 21,526 (93%) 8795 (92%) 1329 (92%)




None 1068 (5%) 365 (4%) 73 (5%)
1 partner 10,893 (47%) 4336 (46%) 410 (28%)
2–4 partners 4037 (17%) 1660 (17%) 506 (35%)
≥5 partners 649 (3%) 206 (2%) 215 (15%)
Missing 6456 (28%) 2963 (31%) 244 (17%)
New partnersc No 2658 (28%) –
Yes 2663 (28%) –
Missing 4209 (44%) –
Condom use at last
sex
No 3881 (41%) –
Yes 2014 (21%) –




No – 786 (54%)
Yes – 124 (9%)
Missing – 538 (37%)
Condomless anal
sexc
No – 419 (29%)
Yes – 535 (37%)




No – 138 (10%)
Yes – 350 (24%)
Missing – 960 (66%)
Problematic
alcohol used
No 4558 (20%) 1890 (20%) 192 (13%)
Yes 203 (1%) 102 (1%) 22 (2%)
Missing 18,342 (79%) 7538 (79%) 1234 (85%)
Drug usec No 10,212 (44%) 3860 (41%) 795 (55%)
Yes 1537 (7%) 686 (7%) 199 (14%)
Missing 11,354 (49%) 4984 (52%) 454 (31%)
a These relate to females only in the young people, and in the MSM, self-reported het-
erosexuals who reported same sex male partners were included in the MSM group.
b Within the previous 12 months.
c Within the previous 3 months.
d As assessed and deﬁned by local clinical guidelines.
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hol use and receptive CAI were excluded due to missingness. The pri-
mary model included 36 degrees of freedom, and may therefore be
over-ﬁtted (Table 3).
Overall none of the demographic variables were statistically signiﬁ-
cant, although being of South Asian ethnicity and being born outside of
the UK in Europe had increased odds of STI diagnosis compared to being
White British and born in the UK, respectively. Signiﬁcant behavioural
risks included CAI and recreational drug use in the prior 3-months.
The model had reasonable performance, with a c-statistic of 0.676 and
the Hosmer-Lemeshow test did not raise concerns about model ﬁt (p-
value = 0.224) (Fig. 1b). Following internal cross-validation, the c-
statistic was 0.612, shower poorer discrimination. The predicted proba-
bility of STI diagnosis ranged from 3 to 71%, with a mean predicted risk
of 16%; Fig. 2b shows a higher level of predicted risk across the develop-
ment population, compared to young people, with a gradual increase in
predicted risk of STI diagnosis. As an illustration, a threshold of ≥20%
would give a sensitivity of 66% and speciﬁcity of 60%, but classify 46%
of patients as “high risk”.
The forward stepwise model excluded age, deprivation quintile,
number of partners in the prior 3-months and ethnicity. This model
was favoured by the BIC as more parsimonious, but it had poorer dis-
crimination (c-statistic: 0.658). The multiple imputation model had
comparable performance to the primary model (c-statistic: 0.676).
The predicted risks ranged from 4 to 71%, also showing very similar dis-
crimination, and similar direction and magnitude of relationships with
the outcome. A demographic only model showed poor performance
and discrimination (c-statistic: 0.553), with predicted risks ranging
from 7 to 23%.
3.3. External Validation
A total of 246 MSM and 306 YP successfully self-completed the tri-
age questionnaire during the one-month pilot period, representing
19.8% (N=2697) of all patients who attended the clinic during this pe-
riod. We were able to link 46.2% (n= 246) of these patient episodes to
the clinic's EPR system for the external validation. There were 136
young people, of whom 23.5% (n = 32; 95% CI: 16.7%, 31.6%) had an
STI diagnosis, and 110 MSM with an STI prevalence of 28.1% (n = 31;
95% CI: 20.0%, 37.6%) included in the validation analysis.
Data on sexual history and behaviour had higher completion than
the enhanced GUMCAD dataset, but postcode for calculating depriva-
tion score had lower completion. This pattern was seen in both MSM
and young people (Supplementary Tables 2 and 3). This may reﬂect pa-
tients' willingness to provide information in different formats such as
using self-completed form, or the level of staff compliance in collecting
or documenting information in routine care.
The young person's primarymodel in the external validation dataset
had a c-statistic of 0.539. Using a predicted risk of ≥10%, which has the
best balance between sensitivity and speciﬁcity in the development
model, resulted in a speciﬁcity of b5%, but 100% sensitivity. This
shows poor discrimination. For the MSM model the c-statistic was
0.579, and using a predicted risk of STI diagnosis of ≥30% gave a sensitiv-
ity of 48% and speciﬁcity of 73%. This showed a similar balance between
sensitivity and speciﬁcity to the development dataset, but is a higher
risk cut-off and model discrimination decreased.
4. Discussion
We were able to develop triage models for young people and MSM
using data routinely collected within sexual health clinics in England,
with both models meeting the threshold for being a clinically reason-
able diagnostic tool in development. The inclusion of STI history and
recent behaviours was crucial to meeting the threshold of reasonable
performance and improvements in data qualitymayprovide opportuni-
ties for further reﬁnement. However, balancing sensitivity, speciﬁcity
Table 2















White, other 1.33 0.28 0.95 1.86
South Asian 0.73 −0.32 0.39 1.35
Asian, other 0.94 −0.06 0.49 1.80
Black
Caribbean
2.65 0.98 2.01 3.50
Black, other 1.57 0.45 1.25 1.97
White &
Black mixed
1.85 0.61 1.39 2.45
Mixed, other 0.88 −0.13 0.55 1.41
Other 0.69 −0.37 0.29 1.66




Europe 1.03 0.03 0.72 1.47
Africa 0.66 −0.42 0.44 0.99
Americas 0.77 −0.26 0.50 1.18
Asia 0.42 −0.86 0.09 1.90
Other 0.89 −0.12 0.48 1.62
Missing 0.78 −0.24 0.62 0.98
Age 16–17 years 1.00 0.003
18–19 years 0.77 −0.26 0.59 1.00
20–21 years 0.81 −0.21 0.63 1.05
22–23 years 0.70 −0.36 0.54 0.90








0.91 −0.10 0.74 1.10
Quintile 3
(medium)
1.00 b−0.01 0.80 1.24
Quintile 4
(low)
0.84 −0.18 0.67 1.05
Quintile 5
(lowest)
0.80 −0.23 0.61 1.04











0 partners 1.00 0.023
1 partner 2.16 0.77 1.19 3.91
2–4 partners 2.51 0.92 1.36 4.64
≥5 partners 2.58 0.95 1.28 5.22





























a All variables in the table included in the multivariable model.
b Within the previous 12 months.
c Within the previous 3 months. Model coefﬁcient =−2.34; McFadden's pseudo
R2 = 7.8%. OR = odds ratio.
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may be limited in their practical use in a clinical setting with limited re-
sources for providing risk reduction interventions.
The young person's model identiﬁed several signiﬁcant predictors of
STI diagnosis, which correspond to previously established associations.
Multiple partners and a prior chlamydia diagnosis are established risks
for STIs amongst young people [32–34], and being of black (including
Black Caribbean) or mixed white and black ethnicity agrees with previ-
ous ﬁndings from the UK [35,36]. Possible explanations for these associ-
ations are different levels of sexual health knowledge, and therefore
behaviours, amongst younger and black ethnicminorities [37]. Being fe-
male, older than 17 years and reporting condom use at last sex were as-
sociated with lower odds of STI diagnosis, again echoing studies from
other settings [32,38,39].The MSMmodel identiﬁed two signiﬁcant predictors of STI diagno-
sis: having had CAI and drug use in the prior 3-months. The use of rec-
reational drugs amongst MSM as a risk for STI diagnosis corresponds to
ﬁndings from multiple studies [40–42]. The lack of association with
number of recent partners contradicted published literature, although
it should be noted that there was a trend in the adjusted odds ratios
[41,43,44]. When we used a forward stepwise approach, number of
partners was not retained in the model, along with age, deprivation
and ethnicity. This may be the result of correlation between drug use
and partner numbers, or that MSM attending sexual health clinics
have higher numbers of partners than the general population.
External validation showed poor ability for themodels to predict STI
diagnosis in a different clinical setting than the development data. Val-
idation, both internal and external, generally shows worse model per-
formance indicators than development models, so to some extent this
was expected. However, additional contributing factors may have
been the difference in STI prevalence between datasets, which was
more pronounced in YP where performance declined more (YP: 11%
versus 24%;MSM: 22% versus 28%). The demographic distribution of pa-
tients in the validation dataset differed considerably from the develop-
ment dataset, and represented one clinical service (Supplementary
Tables 2 and 3). As the risk of STI diagnosis at the population level varies
according to demographics, it is likely that in different regions these de-
mographic factors will vary in signiﬁcance according to the local epide-
miology. This raises a more general challenge with using standardised
prediction models derived from national data, to increase power and
generate robustmodels. However, if themagnitude or direction of asso-
ciation between predictors and the outcome vary between clinics or re-
gions, then this approach may be unreasonable. More sophisticated
machine learningmethods for triage tool development could lead to im-
provedmodel performance, but need to balance statistical performance
with interpretability and real-world application in a clinical setting. Pre-
vious research has shown that transparency in algorithms and their as-
sumptions are important to service providers, so a simplistic approach
to development could be a strength during implementation [45].
Another explanation for the reduced discrimination in the validation
could be the way in which the information was collected, with patients
self-completing the questions instead of answering them in consulta-
tionwith a healthcare provider. A previous study in sexual health clinics
found that patients reported higher levels of sexual risk behaviours
when self-completing, compared to face-to-face consultations [46].
This is likely supported by our ﬁndings, with no missing data recorded
on the number of partners in the prior 3-months for MSM or YP in the
validation, compared to 17% and 31% in the development dataset, re-
spectively. This suggests patients may be more willing to report these
outside of a clinical consultation (e.g. drug use in MSM), and therefore
the associations between these questions and STI diagnosiswould likely
differ from the development dataset. Alternatively, it may be that this
data is collected during routine consultations, but healthcare providers
do not comply with documentation requirements, reducing the quality
of routinely collected data.
While there were similarities in demographics between young peo-
ple and MSM and the wider clinic populations from the ﬁve pilot sites,
these sub-populationsmay not be representative of attendances at sex-
ual health services nationally. For MSM speciﬁcally, the STI diagnosis
rate in the development population was higher than the nationally-
reported rate for the same time period (22.0% versus 14.9%), however,
noneof the large London clinicswhich have higher numbers ofMSMpa-
tients were included in our analyses [47].
This study had several strengths and limitations, the main strength
being the implementation of an external prospective validation, a ro-
bustmethod ofmodel validation [31]. Despite beingbest practice, exter-
nal validation is rarely conducted alongside model development,
limiting conclusions about real-world applicability. However, we ac-
knowledge that the sample of patients whose self-completed electronic
data could be linked to clinic EPR data was small, and those included in
Fig. 1. Receive Operating Characteristic (ROC) curves for STI diagnosis in young people and MSM (development models). a: Young people; b: MSM.
48 C. King et al. / EClinicalMedicine 4–5 (2018) 43–51analysis had some differences in demographics to the clinic population
(e.g. more heterosexual men and fewer young white British partici-
pants). This may have biased the performance of the triage model dur-
ing validation, and limits the strength of our conclusions about external
performance. The prospective study provided valuable lessons about al-
gorithm implementation, with challenges, including differences in risk
proﬁles between clinical settings, as well as opportunities to for further
investigation, such as patient self-triage.
A key limitation was the high levels of missingness in the develop-
ment dataset, and restrictions that using routine data posed (e.g. binary
gender classiﬁcation, or the lack of presenting symptom information).
This was a dataset developed as part of a pilot implementation, where
part of the purpose was to determine the feasibility of implementation
and data quality. BASHH guidelines recommend the collection of these
key sexual history and behavioural variables,which are deemed feasibleto collect in routine care, especially in sexual health clinics [20]. How-
ever, it may be that in practice this is not routinely done, or as clinics
were piloting a new system, not all staff were aware that these needed
to be documented. As missingness differed between young people and
MSM, it suggests these risks are not consistently investigated with all
patients. Rather, clinical staff are selective in who they ask and record
data for, based on assumptions relating to personal characteristics or
local clinic policies, which could result in ascertainment bias. For exam-
ple, MSMwere more likely to have drug use recorded than young peo-
ple (69% vs. 48%), potentially reﬂecting provider's awareness of
chemsex being more common in this group and a sexual risk factor
thus impacting on their clinical decision-making [48]. More complete
behavioural data may have improved model performance, and allowed
for additional variables to be included (e.g. problematic alcohol use).
This is likely to have somewhat limited the predictive performance,
Fig. 2. Risk predictiveness curves for STI diagnosis in young people and MSM (development models). a: Young people; b: MSM.
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mary model was ﬁt with 36 degrees of freedom for 318 outcomes; in
order to avoid over-ﬁtting a minimum of 360 STI diagnoses amongst
MSM would have been required.
Triaging patients according to their risk of STI diagnosis using rou-
tinely collected data within sexual health clinics was feasible; however,
at a minimum, basic behavioural data are needed to improve the dis-
crimination of these models. The ability to include additional, or more
complete, behavioural data would likely improve performance further.
However, the feasibility of using these models at a national scale in a
standardised way may not be achievable, as patient populations may
vary in their risk associations across different clinics and geographicalregions. Further model reﬁnement, potentially exploring machine
learning methodologies, and subsequent external validation are still
needed. Additionally, further investigation on whether this approach
may be more suitable to online patient pathways, which are becoming
increasingly common for sexual health, would be valuable [49]. An on-
line algorithm could be developed and applied to a patient's self-
completed questionnaire, to ensure those at higher risk of STI diagnosis
are directed towards appropriate services, such as a clinical appoint-
ment versus self-testing kit sent to their home.While this work demon-
strated that developing such a tool was feasible using routine data,
further reﬁnement, validation and assessments of the real-world appli-
cability are still needed.
Table 3






Ethnicity White British 1.00 0.351
White, other 0.67 −0.40 0.35 1.30
South Asian 2.53 0.93 1.05 6.10
Asian, other 1.43 0.36 0.48 4.21
Black
Caribbean
0.57 −0.56 0.20 1.67
Black, other 0.98 −0.02 0.47 2.03
White &
Black mixed
0.76 −0.28 0.29 1.97
Mixed, other 1.19 0.17 0.53 2.70
Other 1.05 0.04 0.28 3.90




Europe 2.46 0.90 1.26 4.78
Africa 1.00 0.002 0.42 2.42
Americas 1.43 0.36 0.60 3.40
Asia 1.23 0.21 0.37 4.16
Other 0.88 −0.13 0.33 2.32
Missing 0.65 −0.43 0.35 1.23
Age 16–19 years 1.00 0.297
20–24 years 0.75 −0.28 0.41 1.39
25–34 years 0.79 −0.24 0.44 1.39
35–44 years 0.63 −0.47 0.34 1.17
45–64 years 0.55 −0.59 0.29 1.06








0.93 −0.07 0.63 1.36
Quintile 3
(medium)
0.87 −0.14 0.57 1.32
Quintile 4
(low)
1.08 0.08 0.72 1.63
Quintile 5
(lowest)
0.66 −0.41 0.41 1.07









0 partners 1.00 0.442
1 partner 1.24 0.21 0.55 2.76
2–4 partners 1.30 0.26 0.58 2.93
≥ 5 partners 1.70 0.53 0.73 3.97














































a All variables in the table included in the multivariable model.
b Within the previous 12 months.
c Within the previous 3 months. Model coefﬁcient = −1.73; McFadden's pseudo
R2 = 7.0%. OR = odds ratio.
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